Empowering Advanced Practice Providers to Adopt Routine Screening for Tardive Dyskinesia.

Authors: LaCouture, Amy, Trinh, Linda

Source: Psychiatric Times; Feb2025, Vol. 42 Issue 2, Special section p1-4, 4p

Vitexin Mitigates Haloperidol-Induced Orofacial Dyskinesia in Rats through Activation of the Nrf2 Pathway.

Authors: Chen, Shu-Mei^1,2 (AUTHOR) nschenis@gmail.com, Wang, Mao-Hsien³ (AUTHOR) momonini@me.com, Chang, Kuo-Chi^4,5 (AUTHOR) steven580704@yahoo.com.tw, Fang, Chih-Hsiang⁶ (AUTHOR) danny07291991@hotmail.com, Lin, Yi-Wen⁷ (AUTHOR) zhew520@gmail.com, Tseng, Hsiang-Chien^8,9 (AUTHOR) m005356@ms.skh.org.tw

Source: International Journal of Molecular Sciences. Sep2024, Vol. 25 Issue 18, p10206. 15p.

Subject Terms: *OXIDANT status, *TARDIVE dyskinesia, *HERBAL medicine, *NUCLEAR factor E2 related factor, *DYSKINESIAS

Clozapine-induced acute akathisia: A case report.

Authors: Abhilasha, Pallavi¹ (AUTHOR) pallaviabhilasha@yahoo.com, Bhatti, Neena² (AUTHOR), Joseph, Girish² (AUTHOR), Injety, Ranjit J.³ (AUTHOR)

Source: Journal of Family Medicine & Primary Care. Sep2024, Vol. 13 Issue 9, p4099-4102. 4p.

Subject Terms: *TARDIVE dyskinesia, *PROPRANOLOL, *CLOZAPINE, *CLONAZEPAM, *PEOPLE with schizophrenia

Clinical Utility of Deutetrabenazine as a Treatment Option for Chorea Associated with Huntington's Disease and Tardive Dyskinesia.

Authors: Frank, Samuel (AUTHOR), Alakkas, Aljoharah (AUTHOR)

Source: Therapeutics & Clinical Risk Management. Dec2023, Vol. 19, p1019-1024. 6p.

Subject Terms: *HUNTINGTON disease, *TARDIVE dyskinesia, *DOPAMINE agents, *DRUG efficacy, *CHOREA

This result is not displayed to guests.
Login for full access.

REFRAMING APPROACHES TO SCHIZOPHRENIA. (cover story)

Authors: Weiden, Peter J.¹

Source: Psychiatric Times; Jul2024, Vol. 41 Issue 7, p1-13, 4p

Efficacy and safety of Transcranial Direct Current Stimulation (tDCS) on cognitive function in chronic schizophrenia with Tardive Dyskinesia (TD): a randomized, double-blind, sham-controlled, clinical trial.

Authors: Zhou, Yue^1,2 (AUTHOR), Xia, Xingzhi^1,2 (AUTHOR), Zhao, Xueli² (AUTHOR), Yang, Ruchang^2,3 (AUTHOR), Wu, Yuxuan^2,3 (AUTHOR), Liu, Junjun⁴ (AUTHOR), Lyu, Xiaoli⁵ (AUTHOR), Li, Zhe² (AUTHOR), Zhang, Guangya² (AUTHOR), Du, Xiangdong^1,2 (AUTHOR) xiangdong-du@163.com

Source: BMC Psychiatry. 8/24/2023, Vol. 23 Issue 1, p1-9. 9p. 4 Charts.

Subject Terms: *TRANSCRANIAL direct current stimulation, *TARDIVE dyskinesia, *COGNITIVE ability, *RECOGNITION (Psychology), *CLINICAL trials

Adjunctive cariprazine for the treatment of major depressive disorder: Number needed to treat, number needed to harm, and likelihood to be helped or harmed.

Authors: Citrome, L.¹ (AUTHOR) nntman@gmail.com, Reda, I.^1,2 (AUTHOR), Kerolous, M.^1,2 (AUTHOR)

Source: Journal of Affective Disorders. Jan2025, Vol. 369, p1238-1247. 10p.

Subject Terms: *MENTAL depression, *TARDIVE dyskinesia, *PLACEBOS, *ANTIPSYCHOTIC agents

A Case Report of Lurasidone-Induced Tardive Dyskinesia: Therapeutic Role of Valbenazine.

Authors: Jha, Ambika Nand¹ nandjha99@gmail.com, Gaikwad, Varsha Ratan²

Source: Pharmacy & Pharmaceutical Sciences Journal / Jurnal Farmasi Dan Ilmu Kefarmasian Indonesia. Dec2024, Vol. 11 Issue 3, p269-273. 5p.

Subject Terms: *TARDIVE dyskinesia, *ANTIPSYCHOTIC agents, *DOPAMINE receptors, *QUALITY of life, *DRUG side effects

Acknowledgement to Referees.

Source: CNS Drugs. Dec2024, Vol. 38 Issue 12, p943-947. 5p.

Subject Terms: *TARDIVE dyskinesia, *SEIZURES (Medicine), *ACADEMIC medical centers, *ISCHEMIC stroke, *HUNTINGTON disease, *PRASUGREL, *BENZODIAZEPINES, *MONOCLONAL antibodies

A network meta-analysis of KarXT and commonly used pharmacological interventions for schizophrenia.

Authors: Wright, Abigail C.¹ (AUTHOR) awright@icer.org, McKenna, Avery¹ (AUTHOR), Tice, Jeffrey A.² (AUTHOR), Rind, David M.¹ (AUTHOR), Agboola, Foluso¹ (AUTHOR)

Source: Schizophrenia Research. Dec2024, Vol. 274, p212-219. 8p.

Subject Terms: *MUSCARINIC receptors, *TARDIVE dyskinesia, *DRUG therapy, *INVESTIGATIONAL drugs, *WEIGHT gain

Successful Electroconvulsive Therapy for Tardive Dyskinesia and Tardive Dystonia Refractory to Valbenazine Treatment: A Case Report and Narrative Literature Review.

Authors: Keisuke Irinaka¹, Yu Itoh¹, Kazuhisa Yoshizawa¹, Masaya Ogasawara¹, Naoko Ayabe², Kazuo Mishima¹, Masahiro Takeshima¹ m.takeshima@med.akita-u.ac.jp

Source: Clinical Psychopharmacology & Neuroscience. Nov2024, Vol. 22 Issue 4, p688-696. 9p.

Subject Terms: *TARDIVE dyskinesia, *ELECTROCONVULSIVE therapy, *BOTULINUM toxin, *DOPAMINE receptors, *ARIPIPRAZOLE

Tardive Dyskinesia with Antipsychotic Medication in Children and Adolescents: A Systematic Literature Review.

Authors: Besag, Frank M. C.^1,2,3 (AUTHOR) fbesag@aol.com, Vasey, Michael J.¹ (AUTHOR), Salim, Iffah⁴ (AUTHOR), Hollis, Chris^5,6,7 (AUTHOR)

Source: Drug Safety. Nov2024, Vol. 47 Issue 11, p1095-1126. 32p.

Subject Terms: *TARDIVE dyskinesia, *DRUG therapy, *DOPAMINE receptors, *ANTIPSYCHOTIC agents, *MOVEMENT disorders, *DOPAMINE antagonists

A Model‐Informed Drug Development Approach Supporting the Approval of an Unstudied Valbenazine Dose for Patients With Tardive Dyskinesia.

Authors: Nguyen, Hoa Q.¹ avnguyen@neurocrine.com, Kuan, Han‐Yi Steve¹, Crass, Ryan L.², Quinlan, Lauren², Chapel, Sunny², Kim, Kristine¹, Brar, Satjit¹, Loewen, Gordon¹

Source: Journal of Clinical Pharmacology. Nov2024, Vol. 64 Issue 11, p1456-1465. 10p.

Subject Terms: *HETEROCYCLIC compounds, *TARDIVE dyskinesia, *RESEARCH funding, *CARRIER proteins, *STATISTICAL sampling, *BLIND experiment, *PILOT projects, *RANDOMIZED controlled trials, *DESCRIPTIVE statistics, *DOSE-effect relationship in pharmacology, *DRUG approval, *VALINE, *LONGITUDINAL method, *DRUG efficacy, *ADRENERGIC uptake inhibitors, *DRUG development, *COMPARATIVE studies, *CONFIDENCE intervals, *MEMBRANE proteins, *CHEMICAL inhibitors

Geographic Terms: UNITED States

Company/Entity: UNITED States. Food & Drug Administration

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Efficacy and safety of different pharmacological interventions in the treatment of tardive dyskinesia: a systematic review and network meta-analysis.

Authors: Ismail, Omar¹, Albdour, Karam¹ karamalbdour00@gmail.com, Jaber, Yazan¹, Jaber, Kamel¹, Alsaras, Ameen¹

Source: European Journal of Clinical Pharmacology. Oct2024, Vol. 80 Issue 10, p1471-1482. 12p.

Subject Terms: *HETEROCYCLIC compounds, *TARDIVE dyskinesia, *PATIENT safety, *MENTAL illness, *TREATMENT effectiveness, *META-analysis, *DESCRIPTIVE statistics, *SYSTEMATIC reviews, *MEDLINE, *MEDICAL databases, *DRUGS, *ONLINE information services, *CONFIDENCE intervals, *COMPARATIVE studies, *EVALUATION